Breaking News Instant updates and real-time market news.

GCO

Genesco

$38.84

0.14 (0.36%)

06:57
11/04/19
11/04
06:57
11/04/19
06:57

Genesco CEO Robert Dennis to leave role, Mimi Vaughn to succeed

Genesco announced that Mimi Vaughn, currently the company's senior VP and COO, has been named Genesco's next president and CEO, effective February 2, 2020, the start of the company's new fiscal year. In addition, Vaughn was elected to Genesco's board of directors, effective immediately. Vaughn will succeed Robert Dennis, Genesco's current chairman, president and CEO, who will continue to serve as the company's executive chairman. During his 15-year career with the Company, Dennis has led Genesco as president and CEO for 11 years and served as chairman for the past nine years. Matthew Diamond will continue to serve as the company's lead outside director. Vaughn joined Genesco as VP - strategy and business development in 2003, was promoted to senior VP - strategy and business development in 2006, and was named senior VP - strategy and shared services in 2009. Vaughn became CFO in 2015, and was named Genesco's COO in January 2018. She formally assumed the role in May following the appointment of Mel Tucker as CFO.

GCO Genesco
$38.84

0.14 (0.36%)

01/09/19
01/09/19
DOWNGRADE
Target $52

Hold
Genesco downgraded to Hold on valuation 'disconnect' at Pivotal Research
As previously reported, Pivotal Research analyst Mitchel Kummetz downgraded Genesco to Hold from Buy as he senses a disconnect between the company's fundamentals and valuation. He believes performance has deteriorated since Genesco reported its Q3 in early December, as he thinks that the boot category "rolled over" in December, but notes that the stock has appreciated 15% over that time. The stock is now trading at a 13% premium to the group, which "seems a little rich," added Kummetz, who keeps a $52 price target on Genesco shares.
08/27/19
SUSQ
08/27/19
UPGRADE
SUSQ
Positive
Genesco upgraded to Positive from Neutral at Susquehanna
09/09/19
PIVT
09/09/19
UPGRADE
Target $48
PIVT
Buy
Genesco upgraded to Buy from Hold at Pivotal Research
Pivotal Research analyst Mitch Kummetz upgraded Genesco to Buy from Hold and raised his price target for the shares to $48 from $40. Following the company's Q2 beat and guidance increase, the analyst sees an improved fiscal 2021 setup and a "favorable" valuation. He believes Journeys' same-store-sales could remain "positive for a while" and come in better than expected. Further, Kummetz likes how Genesco's fiscal 2021 earnings sets up on share buybacks and the expected reduction of stranded and other costs. In addition, the stock is "too cheap" at a 20% discount to the peer group, the analyst tells investors in a research note.
09/09/19
09/09/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Las Vegas Sands (LVS) upgraded to Buy from Hold at Deutsche Bank with analyst Carlo Santarelli saying Bearish Macau sentiment has created an opportunistic entry point for medium to longer term investors. 2. Genesco (GCO) upgraded to Buy from Hold at Pivotal Research with analyst Mitch Kummetz citing the company's Q2 beat and guidance increase. 3. Entergy (ETR) upgraded to Overweight from Neutral at JPMorgan with analyst Christopher Tenure saying unlike some of its large premium valuation peers, Entergy has potential for both high rate base growth and improving earned returns on equity. 4. SAIC (SAIC) upgraded to Outperform from Market Perform at Cowen with analyst Cai Von Rumohr saying the "sharp selloff" in shares has resulted in favorable risk/reward and raised its price target to $102.00. 5. Chipotle (CMG) upgraded to Outperform from Neutral at Wedbush with analyst Nick Setyan saying as the industry transitions towards a larger mix of digital transactions, the analyst believes Chipotle is in a leading position to establish a digital moat. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$293.92

1.71 (0.59%)

07:33
12/13/19
12/13
07:33
12/13/19
07:33
Hot Stocks
Breaking Hot Stocks news story on Biogen »

Biogen to discontinue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$293.92

1.71 (0.59%)

07:32
12/13/19
12/13
07:32
12/13/19
07:32
Hot Stocks
Biogen: Primary endpoint not statistically significant in Phase 2 PASSPORT study »

Biogen announced topline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

07:32
12/13/19
12/13
07:32
12/13/19
07:32
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CG

Carlyle Group

$29.83

-0.36 (-1.19%)

07:31
12/13/19
12/13
07:31
12/13/19
07:31
Hot Stocks
Funds advised by Apax Partners to acquire Coalfire from Carlyle Group, Chertoff »

Funds advised by Apax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ADBE

Adobe

$305.76

2.01 (0.66%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

SAFM

Sanderson Farms

$166.66

2.5 (1.52%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Initiation
Sanderson Farms initiated  »

Sanderson Farms initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

ORCL

Oracle

$56.47

0.16 (0.28%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Recommendations
Oracle analyst commentary  »

Oracle shares to come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$327.39

7.53 (2.35%)

07:28
12/13/19
12/13
07:28
12/13/19
07:28
Recommendations
Broadcom analyst commentary  »

Broadcom price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCLH

Norwegian Cruise Line

$56.12

0.72 (1.30%)

07:27
12/13/19
12/13
07:27
12/13/19
07:27
Recommendations
Norwegian Cruise Line analyst commentary  »

Norwegian Cruise Line…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

07:26
12/13/19
12/13
07:26
12/13/19
07:26
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ADBE

Adobe

$305.76

2.01 (0.66%)

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

DCP

DCP Midstream

$23.70

-0.56 (-2.31%)

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Initiation
DCP Midstream initiated  »

DCP Midstream initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Conference/Events
UBS analyst manley to hold an analyst/industry conference call »

Analyst Manley discusses…

TDOC

Teladoc

$77.06

-0.36 (-0.46%)

07:24
12/13/19
12/13
07:24
12/13/19
07:24
Initiation
Teladoc initiated  »

Teladoc initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIMT

Aimmune

$31.60

0.78 (2.53%)

07:22
12/13/19
12/13
07:22
12/13/19
07:22
Downgrade
Credit Suisse downgrades Aimmune with peanut allergy approval widely expected »

Credit Suisse analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$162.94

-4.5 (-2.69%)

07:22
12/13/19
12/13
07:22
12/13/19
07:22
Downgrade
Nordson rating change  »

Nordson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$84.00

-2.97 (-3.42%)

07:20
12/13/19
12/13
07:20
12/13/19
07:20
Upgrade
Bluebird Bio rating change  »

Bluebird Bio upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

07:19
12/13/19
12/13
07:19
12/13/19
07:19
Upgrade
Bristol-Myers rating change  »

Bristol-Myers upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNS

Bank of Nova Scotia

$56.73

0.145 (0.26%)

07:19
12/13/19
12/13
07:19
12/13/19
07:19
Downgrade
Bank of Nova Scotia rating change  »

Bank of Nova Scotia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

SKX

Skechers

$41.65

0.89 (2.18%)

07:18
12/13/19
12/13
07:18
12/13/19
07:18
Upgrade
Skechers rating change  »

Skechers upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$41.97

0.95 (2.32%)

07:17
12/13/19
12/13
07:17
12/13/19
07:17
Initiation
Etsy initiated  »

Etsy initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

07:16
12/13/19
12/13
07:16
12/13/19
07:16
Recommendations
Sarepta price target raised to $260 from $160 at H.C. Wainwright »

H.C. Wainwright analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$119.76

0.72 (0.60%)

07:15
12/13/19
12/13
07:15
12/13/19
07:15
Periodicals
Bonobos founder Andy Dunn leaving Walmart in 2020, CNBC reports »

Andy Dunn, the founder of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$179.27

-0.33 (-0.18%)

, MRTX

Mirati Therapeutics

$106.24

0.39 (0.37%)

07:14
12/13/19
12/13
07:14
12/13/19
07:14
Hot Stocks
BeiGene announces clinical data on tislelizumab in combination with sitravatinib »

BeiGene (BGNE) and Mirati…

BGNE

BeiGene

$179.27

-0.33 (-0.18%)

MRTX

Mirati Therapeutics

$106.24

0.39 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

ADBE

Adobe

$305.76

2.01 (0.66%)

07:13
12/13/19
12/13
07:13
12/13/19
07:13
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.